DermTech, Inc.
DMTKQ
$0.00
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.85M | 3.92M | 3.92M | 3.98M | 3.48M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.85M | 3.92M | 3.92M | 3.98M | 3.48M |
| Cost of Revenue | 3.13M | 3.48M | 3.74M | 3.97M | 3.82M |
| Gross Profit | 713.00K | 440.00K | 172.00K | 8.00K | -344.00K |
| SG&A Expenses | 17.96M | 16.84M | 16.39M | 22.75M | 27.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.35M | 23.68M | 23.73M | 30.61M | 35.52M |
| Operating Income | -20.51M | -19.75M | -19.81M | -26.63M | -32.05M |
| Income Before Tax | -20.01M | -19.09M | -19.16M | -31.36M | -31.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.01M | -19.09M | -19.16M | -31.36M | -31.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.01M | -19.09M | -19.16M | -31.36M | -31.27M |
| EBIT | -20.51M | -19.75M | -19.81M | -26.63M | -32.05M |
| EBITDA | -20.02M | -19.31M | -19.36M | -26.16M | -31.58M |
| EPS Basic | -0.58 | -0.56 | -0.57 | -0.99 | -1.02 |
| Normalized Basic EPS | -0.36 | -0.35 | -0.35 | -0.51 | -0.64 |
| EPS Diluted | -0.58 | -0.56 | -0.57 | -0.99 | -1.02 |
| Normalized Diluted EPS | -0.36 | -0.35 | -0.35 | -0.51 | -0.64 |
| Average Basic Shares Outstanding | 34.71M | 34.33M | 33.84M | 31.79M | 30.56M |
| Average Diluted Shares Outstanding | 34.71M | 34.33M | 33.84M | 31.79M | 30.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |